Navigation Links
Termination of IS Clinical From Distributing PhytoCeuticals Formulas
Date:7/2/2008

ELMWOOD PARK, N.J., July 2 /PRNewswire/ -- PhytoCeuticals, Inc., the highly respected developer and manufacturer of proprietary skin care formulations, who is the Fast to invent Stable Liquid L-Ascorbic Acid (Vitamin C), has terminated the agreement granting IS Clinical from Innovative Skin Care the right to exclusively market the proprietary product formulas of PhytoCeuticals, Inc. effective July 1, 2008.

The IS Clinical termination was triggered by that company's introduction of controversial new products, not created by PhytoCeuticals, Inc. that violated Dr. Mostafa M. Omar, presidents of PhytoCeuticals, Inc. medical guidelines. Dr. Omar is also the Professor of Pharmacognosy at the University of Rhode Island, School of Pharmacy commented, "It is my ethical duty as a prominent medical researcher to warn clinicians and patients that, as IS Clinical no longer has access to PhytoCeuticals, Inc. formulas and products, I cannot warrant the safety of any products sold by IS Clinical."

IS Clinical has received legal notice to remove all references to Dr. Omar and/or PhytoCeuticals, Inc., including all research citations, product claims and other related materials from all websites, advertising materials, media releases, packaging and product literature. Also IS Clinical is required to issue a clarifying press release informing clinicians and consumers, which products sold by the company prior to July 1, 2008, were actually owned and developed by PhytoCeuticals, Inc. -- a business relationship that no longer exists.

"We will take all action necessary to prohibit IS Clinical from illegal usage of our formulas and research,' added Dr. Omar. "We will protect our scientific integrity and the reputation of our unique, clinically-proven products by any and all legal means."

PhytoCeuticals, Inc. is highly respected developer and manufacturing of proprietary skin care formulations, who is the First to invent Stable Liquid L-Ascorbic Acid (Vitam
'/>"/>

SOURCE PhytoCeuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

5

GOOD

Page: 1 2

Related medicine news :

1. Schering-Plough and Merck Announce Withdrawal of Loratadine/Montelukast NDA and Termination of Respiratory Joint Venture
2. Hologic, Inc. Announces Grant of Early Termination of Antitrust Waiting Period for Third Wave Technologies, Inc. Tender Offer
3. Sun Pharma Responds to Taros Purported Termination of Merger Agreement
4. Spinal Surgery and Determination Save Lioness
5. Elbit Imaging Ltd. Announces Termination of Service of Trustee for Holders of Series A, B and C Notes
6. Inaugural Stanford International Pro-Am Winner A Remarkable Story in Determination And the Powerful Impact of St. Jude Childrens Research Hospital
7. Methodist Healthcare - Memphis Hospitals Announces Termination of Tender Offers
8. VaxGen Restructures Following Termination of Proposed Merger
9. Reynolds American Subsidiary to Receive Payment Following Gallaher Joint-Venture Termination
10. TeamStaff Receives Nasdaq Determination Letter
11. IDM Pharma Announces Termination of UVIDEM Development Collaboration and Expected Restructuring in Connection With Evaluation of Strategic Alternatives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... May 18, 2013 TheBeautyPlace.com answers important ... hair loss is not a result of stress, nutrient ... Men’s Fitness Magazine, 70% of men suffer from male ... is renowned for hair transplant surgery, but additionally ... pattern baldness known as Bosley Professional Strength. Their product ...
(Date:5/18/2013)... Mobile, AL (PRWEB) May 18, 2013 ... several malignant tumors, the association between obesity and esophageal ... that for other obesity-related tumors. As reported ... obese people are almost twice as likely as those ... disease. Although the relationship between obesity and esophageal cancer ...
(Date:5/18/2013)... Adolescents, especially young males, who experiment with ... are landing in emergency rooms across America. ... with a new treatment program for those addicted ... from the National Institute on Drug Abuse, synthetic marijuana ... teenagers. In 2012, 11 percent of high school seniors ...
(Date:5/18/2013)... CA (PRWEB) May 18, 2013 Rio ... has recently completed a stylish renovation that features tranquil, ... specialties. , From the ground up, this Morro ... with fresh flooring, soothing colors and comfortable spa beds. ... installed, including an Apilus epilator machine. The shampoo ...
(Date:5/18/2013)... Spectrum Surgical Instruments will attend ... in Austin, TX where thousands of GI nursing ... opportunities. , Spectrum Surgical/STERIS will feature its ... capabilities and certified pre-owned equipment. Attendees will ... proper instrument care of flexible endoscopes. , ...
Breaking Medicine News(10 mins):Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 2Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 3Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 2Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 3Health News:Spice Addiction Treatment and Synthetic Marijuana Drug Rehab Announced by Recovery Associates 2Health News:Rio Salon and Spa, a Beauty Salon in Morro Bay, Undergoes Makeover 2Health News:Spectrum Surgical Attends Society of Gastroenterology Nurses and Associates' (SGNA) 40th Annual Conference in Austin, TX 2
... new information on the prevalence of certain gum-disease-causing oral ... of the bacteria with oral bone loss. ... to cause periodontal disease were more likely to have ... oral pathogens. ,Two widely recognized periodontal pathogens, ...
... to results of a 227 patient Phase 2 trial presented ... mg and 180 mg (with background methotrexate) reduces the progression ... human monoclonal antibody which binds to and inhibits the RANK ... formation, function, and survival and thereby plays a key role ...
... current drug surveillance system needs to be fixed, argues an ... follows a recent analysis of the diabetes drug rosiglitazone (Avandia) ... ,Rosiglitazone was approved by the US Food and Drug Administration ... in 2000. Its popularity has increased steadily, with more than ...
... that is a marker for gastric aspiration, are associated with ... researchers in the United Kingdom . This research provides further ... than alloimmunity, the attack the body mounts to protect itself ... taking of stomach fluids into the lung] may contribute to ...
... are considering an overhaul in the process used to ... . ,Last fall, grocers and shoppers were in ... linked to contaminated bagged spinach. Nationwide there were 204 ... deaths. ,The FDA concluded it could not definitively ...
... to the Church of England for featuring a prominent British ... the church said Friday. ,The Japanese firm had ... they had not intended to cause offence by using the ... he added. ,"If we have done so, ...
Cached Medicine News:Health News:Post Menopausal Women are Prone to Gum Disease 2Health News:Denosumab Reduces Bone Erosion 2Health News:Drug Surveillance System Needs to Be Fixed 2Health News:Rejection in Lung Transplants Due to Elevated Pepsin Level 2Health News:FDAs Failure Urges It to Reassess Its Policies 2
(Date:5/17/2013)... May 17, 2013  Sanofi (EURONEXT: SAN and NYSE: ... JAKARTA , examining the selective JAK2 ... in both dose groups. The primary endpoint assessed the ... Consistent with data reported in previous trials, the most ... Full results will be presented at an upcoming medical ...
(Date:5/17/2013)... Biotech Ltd. (Nasdaq: SVA ), a leading provider ... that it will release its unaudited financial results for the ... May 28, 2013.  The Company will host a conference call ... 28, 2013 at 8:00 p.m. China Standard Time) to review ... corporate developments. To access the conference call, please ...
(Date:5/16/2013)... and ZURICH , May 17, 2013 ... for Science, Technology and Research (A*STAR) and Switzerland,s ... healthy volunteer has been dosed in a Phase 1 clinical ... proprietary bacteriophage Qbeta virus-like particle (VLP) technology. In this first ... novel vaccine candidate and its potential to protect against H1N1 ...
Breaking Medicine Technology:Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: